How to Value an Imaging Center in 2026
Outpatient imaging centers sit at an interesting intersection in healthcare M&A. They're capital-intensive like hospitals, referral-dependent like physician practices, and increasingly attractive to the same private equity platforms that have consolidated dentistry, dermatology, and ophthalmology. I've worked on imaging transactions ranging from single-site MRI centers in rural markets to multi-location networks with $30M in revenue, and the valuation dynamics differ dramatically based on modality mix, payer composition, and competitive position.
Our database includes 88 imaging center transactions with a median EBITDA multiple of 6.9x and a revenue multiple of 1.2x. The consolidation trend is unmistakable — hospital systems and PE-backed platforms are actively acquiring freestanding centers, creating a favorable seller's market for well-positioned operations.
Modality Mix Is the Primary Value Driver
Not all imaging is created equal, and the modality mix of your center is the single biggest determinant of both margins and valuation. The economics vary enormously by imaging type.
MRI is the highest-margin modality in outpatient imaging. A 1.5T MRI might cost $1-1.5M to purchase, and a 3T unit runs $2-3M, but reimbursement per scan ($500-2,000 depending on body part and payer) makes the unit economics compelling. An MRI center running 25-30 scans per day at strong payer mix can generate $3-5M in annual revenue from a single magnet. Centers with MRI as their primary modality consistently trade at the top of the multiple range.
CT is the workhorse — high volume, moderate reimbursement, and lower equipment costs ($300K-$1.5M depending on slice count). CT centers generate reliable revenue but thinner margins than MRI. The scan volume matters enormously: a CT scanner running 40+ scans per day is a cash machine, while one running 15 scans per day may barely cover its fixed costs.
PET/CT is a specialized high-value modality primarily serving oncology patients. PET scanners cost $2-3M but reimbursement per scan is the highest in imaging ($1,500-$3,000+). Centers with PET capability and oncology referral relationships are among the most valuable imaging assets in the market.
X-ray and ultrasoundare low-margin, high-volume commodities. As standalone modalities, they don't drive meaningful value. But as part of a multi-modality center, they provide patient access points and referral physician convenience that supports the higher-margin modalities.
The ideal profile from a valuation standpoint is a multi-modality center with MRI and CT as the revenue anchors, PET/CT as a high-margin specialty, and X-ray/ultrasound for referral convenience. Single-modality centers — particularly standalone X-ray or ultrasound operations — trade at significant discounts.
Equipment: The Dominant Asset and the Biggest Risk
In most businesses I value, equipment is a secondary consideration. In imaging, it's central. The equipment roster — age, condition, technology level, and remaining useful life — directly impacts valuation because replacement costs are enormous and technology evolves rapidly.
A 3T MRI that's 3 years old with current software is a fundamentally different asset than a 1.5T unit that's 12 years old and two software generations behind. Radiologists prefer newer equipment because image quality is better. Referring physicians prefer newer equipment because their patients expect it. And buyers know that an aging fleet means capital expenditure within 2-3 years of closing.
I always advise sellers to get an independent equipment appraisal before going to market. Know the fair market value and remaining useful life of every major piece of equipment. If you have a $2M MRI that's approaching end of useful life, buyers will deduct the replacement cost (or a significant portion of it) from their offer. Better to replace the magnet before selling if the economics support it — a new 3T MRI can pay for itself in enhanced valuation.
Service contracts are another critical factor. Equipment under manufacturer service agreements (OEM contracts from Siemens, GE, Philips) provides buyers with predictable maintenance costs. Equipment covered by third-party service contracts or, worse, serviced on a break-fix basis creates uncertainty that compresses offers.
Referral Relationships and Scan Volume
An imaging center without referring physicians is an expensive collection of magnets and scanners. The referral network is the lifeblood of the business, and its concentration, stability, and depth directly drive valuation.
The metric I focus on first: what percentage of scan volume comes from the top 5 referring physicians or groups? If a single orthopedic practice sends you 30% of your MRI volume, you have concentration risk that mirrors the customer concentration problem I see across every industry. If that practice opens their own in-office MRI or shifts referrals to a competitor, you lose a third of your highest-margin revenue overnight.
Diversified referral bases — no single physician group above 10-15% of volume, with a healthy mix of orthopedics, neurology, oncology, primary care, and emergency medicine — command premium multiples. These centers are more resilient to the loss of any individual referral source.
Scan volume trends over the trailing 24 months are the second thing buyers examine. Growing scan volume indicates strong referral relationships and market demand. Declining volume requires explanation — is it competitive pressure, a lost referral source, payer reimbursement changes, or something else? Declining volume without a clear recovery path will materially impact your multiple.
Payer Mix and Reimbursement Dynamics
Payer mix in imaging has an outsized impact on profitability. The spread between commercial and Medicare reimbursement for the same scan can be 3-4x. A center with 60% commercial payer mix and 20% Medicare operates in a completely different margin structure than one that's 30% commercial and 45% Medicare.
Medicare reimbursement for imaging has been under consistent pressure, with the MPFS (Medicare Physician Fee Schedule) reducing technical component payments for many imaging codes over the past several years. Centers heavily dependent on Medicare face margin compression that buyers will project forward. If you can demonstrate efforts to shift payer mix toward commercial patients — through referral relationship development, geographic positioning, or specialty focus — that trajectory is worth highlighting.
Workers' compensation and auto insurance cases are high-reimbursement segments worth tracking separately. Centers near employment hubs or with relationships to occupational medicine practices can develop meaningful workers' comp volume at premium reimbursement rates.
What the Size Brackets Show
The size-based transaction data reveals the consolidation premium clearly. Under $5M in enterprise value, imaging centers trade at 4.8x EBITDA and 0.9x revenue. These are typically single-site operations with one or two modalities, limited management infrastructure, and concentrated referral bases.
In the $5-25M range, the EBITDA multiple actually compresses slightly to 4.3x, but revenue holds at 0.99x. This counterintuitive pattern reflects the fact that mid-market imaging centers often carry higher overhead (management, compliance, radiology group contracts) that compresses EBITDA margins even as revenue grows. It also reflects the transition zone where centers are large enough to attract institutional buyers but not yet large enough to command platform-level premiums.
The real premium kicks in at scale — multi-site networks with 5+ locations, diversified modalities, and centralized operations attract strategic premiums from hospital systems and PE platforms that can be 2-3x the single-site multiples.
Regulatory Factors: CON States and Accreditation
Certificate of Need (CON) states create artificial barriers to competition that directly enhance the value of existing imaging centers. If you operate in a state that requires CON approval to add imaging equipment, your competitors can't simply open a center across the street. That regulatory moat is real and valuable.
In CON states, the certificate itself is often valued separately from the operating business. I've seen CON-protected imaging centers command 1-2x EBITDA multiple premiums over comparable centers in open-market states. Buyers understand that the CON represents years of regulatory process that they'd have to replicate (with no guarantee of success) to enter the market organically.
ACR (American College of Radiology) accreditation is table stakes for serious buyers. If you're not ACR-accredited, get it before going to market. Many commercial payers require ACR accreditation for reimbursement, and hospital system buyers will require it as a condition of acquisition.
Joint Ventures with Radiology Groups
Many imaging centers operate as joint ventures between equipment owners/operators and radiology groups that provide professional interpretation services. These JV structures can be complex from a valuation standpoint because the economics are split between the technical component (facility, equipment, technologists) and the professional component (radiologist interpretation).
If your center operates under a JV structure, the valuation will depend heavily on the terms of the radiology agreement. Is it exclusive? What's the term? Are the radiologists equity holders or contracted? A long-term exclusive agreement with a high-quality radiology group adds value because it ensures continuity of the professional component. A short-term or non-exclusive arrangement creates transition risk that buyers will price in.
For centers that employ or contract radiologists directly, the quality and stability of the radiology team matters. Subspecialty radiologists (neuroradiology, musculoskeletal, breast imaging) who can provide subspecialty reads add value because they attract referrals from physicians who want expert interpretation.
Positioning Your Imaging Center for Sale
If you're considering selling your imaging center, start with the equipment. Get current appraisals, ensure service contracts are in place, and if any major equipment is approaching end of life, make the capital investment now. Nothing kills imaging deals faster than a buyer discovering they need a $2M magnet replacement in year one.
Document your referral relationships. Create a referral source analysis showing volume by physician, specialty, and trend. If you have written referral agreements or preferred relationships, those are assets. If your referral base is diversified and growing, prove it with data.
Clean up your payer contracts. Ensure you're credentialed with all major commercial payers and that your contracted rates are current. Outdated payer contracts with below-market rates are surprisingly common and represent easy upside that buyers will eventually capture — but you should capture it first and let it flow through your trailing financials.
The Bottom Line
Imaging center valuation is driven by modality mix, equipment condition, referral diversification, and payer composition. The consolidation wave continues to create opportunities for well-positioned sellers, particularly multi-modality centers with modern equipment and diversified referral bases in CON-protected markets. The buyers are active — hospital systems expanding outpatient networks, PE platforms building imaging roll-ups, and radiology groups vertically integrating. Position your center with strong equipment, clean data, and broad referral relationships, and the healthcare M&A market will reward you for it.
Want to see what your business is worth?
Institutional-quality estimates backed by 25,000+ real M&A transactions.
Get Your Valuation EstimateRelated Reading
How to Value an Ambulatory Surgery Center
ASCs share many valuation dynamics with imaging centers — payer mix, physician relationships, and PE interest.
Healthcare M&A Trends in 2026
The consolidation wave driving imaging center valuations is part of a broader healthcare M&A trend.
How to Value a Medical Practice
Physician practices and imaging centers are increasingly valued together as integrated care platforms.